Ozempic
How to use Ozempic for weight loss
7 min read · Updated September 2026 · Reviewed by the Miva clinical team
Ozempic has dominated headlines, but in Canada it is authorised by Health Canada for the management of type 2 diabetes — not weight loss. Wegovy is the semaglutide brand licensed for chronic weight management.
Both are made by Novo Nordisk and both contain semaglutide, a GLP-1 receptor agonist that reduces appetite and slows digestion. This guide explains why Ozempic causes weight loss, how it is used, and where it differs from Wegovy.
Using Ozempic for weight loss
Canadian physicians may prescribe Ozempic off-label for weight loss, using clinical judgement to prescribe outside the authorised indication. Because Ozempic is titrated to lower doses appropriate for blood sugar control, it is generally slightly less potent for weight loss than higher-dose Wegovy — though most patients still lose weight through reduced calorie intake.
Your prescriber will review your BMI, medical history and current medicines before deciding whether treatment is appropriate.
Ozempic dosage
Doses step up every four weeks to limit side effects. Each pen delivers four weekly doses.
| Weeks | Weekly dose |
|---|---|
| 1–4 | 0.25 mg (starting dose, for tolerance) |
| 5–8 | 0.5 mg |
| 9–12 | 1 mg |
| 13+ | Up to 2 mg maximum, if clinically appropriate |
Where and how to inject
Ozempic is a once-weekly subcutaneous injection into the abdomen, front of the thigh or back of the upper arm. Rotate the exact spot each week, keep the pen refrigerated before first use, and dispose of needles in a sharps container.
The pen dose counter shows how much is left; if the remaining amount is less than your dose, use a new pen rather than splitting a dose across two.
How long does it take to work?
Appetite changes are often noticeable within the first weeks, but meaningful weight change usually appears over the first three months as doses increase. It does not work for everyone — response varies with biology, dose tolerated and lifestyle changes made alongside it.
Side effects
Side effect profile mirrors other GLP-1 medicines and is mostly digestive.
- Nausea, vomiting, diarrhoea, constipation and abdominal pain
- Gas, burping and changes to taste
- Dizziness, fatigue and headaches, often linked to dehydration or low intake
- Rarely: pancreatitis (severe abdominal pain radiating to the back — seek urgent care) and worsening diabetic retinopathy in people with diabetes
Ozempic vs Wegovy at a glance
| Ozempic | Wegovy | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Health Canada indication | Type 2 diabetes | Chronic weight management |
| Dose range | 0.25 mg to 2 mg weekly | 0.25 mg to 2.4 mg weekly |
| Use for weight loss | Off-label | On-label |
Frequently asked questions
Can I take Ozempic and Wegovy together?
No. They contain the same active ingredient, and taking both would be a double dose of semaglutide.
Is Ozempic covered in Canada?
Many provincial plans and private insurers cover Ozempic for type 2 diabetes. Coverage for weight loss is uncommon, and off-label prescriptions are often paid out of pocket.
What if I want an on-label weight loss option?
Wegovy is authorised in Canada for weight management, and tirzepatide options are also available. A clinician can advise which is suitable for you.
Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines in Canada. This page is general information, not medical advice — a Canadian-licensed clinician reviews every assessment and decides whether treatment is suitable for you.
Join the Miva list
Sign up now
Leave your email and we’ll let you know the moment consultations open, plus early access to Miva treatment pricing.
No spam. Unsubscribe at any time. We never share your details.